| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |